Prostatic stromal proliferations: a review.
Identifieur interne : 000170 ( Main/Exploration ); précédent : 000169; suivant : 000171Prostatic stromal proliferations: a review.
Auteurs : David G. Bostwick [États-Unis] ; Lars Egevad [Suède]Source :
- Pathology [ 1465-3931 ] ; 2020.
Abstract
Prostatic stromal proliferations account for the majority of benign tumour-like lesions in the prostate. The most common is nodular hyperplasia, seen in a majority of elderly men. Diagnostic difficulty is encountered with some variants, including stromal hyperplasia with atypia, characterised by degenerative changes of myofibroblasts. In contrast with benign stromal tumours, malignant stromal tumours of the prostate are rare, accounting for less than 0.1% of all prostatic malignancies. The most common are rhabdomyosarcoma (paediatric) and leiomyosarcoma (adults); others include phyllodes tumour and stromal sarcoma. Some authors lump malignant tumours with poor outcome (e.g., phyllodes tumour and stromal sarcoma) with benign stromal tumours (e.g., stromal hyperplasia with atypia, leiomyoma), considering them collectively to be of uncertain malignant potential, but this approach is discouraged. This review presents a contemporary approach to classification and diagnosis of prostatic stromal tumours.
DOI: 10.1016/j.pathol.2020.09.017
PubMed: 33190920
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prostatic stromal proliferations: a review.</title><author><name sortKey="Bostwick, David G" sort="Bostwick, David G" uniqKey="Bostwick D" first="David G" last="Bostwick">David G. Bostwick</name><affiliation wicri:level="2"><nlm:affiliation>Bostwick Laboratories, A Division of Poplar Healthcare, Orlando, FL, USA. Electronic address: dbostwick@grangergenetics.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Bostwick Laboratories, A Division of Poplar Healthcare, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Egevad, Lars" sort="Egevad, Lars" uniqKey="Egevad L" first="Lars" last="Egevad">Lars Egevad</name><affiliation wicri:level="3"><nlm:affiliation>Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology-Pathology, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:33190920</idno><idno type="pmid">33190920</idno><idno type="doi">10.1016/j.pathol.2020.09.017</idno><idno type="wicri:Area/Main/Corpus">000005</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000005</idno><idno type="wicri:Area/Main/Curation">000005</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000005</idno><idno type="wicri:Area/Main/Exploration">000005</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prostatic stromal proliferations: a review.</title><author><name sortKey="Bostwick, David G" sort="Bostwick, David G" uniqKey="Bostwick D" first="David G" last="Bostwick">David G. Bostwick</name><affiliation wicri:level="2"><nlm:affiliation>Bostwick Laboratories, A Division of Poplar Healthcare, Orlando, FL, USA. Electronic address: dbostwick@grangergenetics.com.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Bostwick Laboratories, A Division of Poplar Healthcare, Orlando, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Egevad, Lars" sort="Egevad, Lars" uniqKey="Egevad L" first="Lars" last="Egevad">Lars Egevad</name><affiliation wicri:level="3"><nlm:affiliation>Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.</nlm:affiliation><country xml:lang="fr">Suède</country><wicri:regionArea>Department of Oncology-Pathology, Karolinska Institute, Stockholm</wicri:regionArea><placeName><settlement type="city">Stockholm</settlement><region nuts="2">Svealand</region></placeName></affiliation></author></analytic><series><title level="j">Pathology</title><idno type="eISSN">1465-3931</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Prostatic stromal proliferations account for the majority of benign tumour-like lesions in the prostate. The most common is nodular hyperplasia, seen in a majority of elderly men. Diagnostic difficulty is encountered with some variants, including stromal hyperplasia with atypia, characterised by degenerative changes of myofibroblasts. In contrast with benign stromal tumours, malignant stromal tumours of the prostate are rare, accounting for less than 0.1% of all prostatic malignancies. The most common are rhabdomyosarcoma (paediatric) and leiomyosarcoma (adults); others include phyllodes tumour and stromal sarcoma. Some authors lump malignant tumours with poor outcome (e.g., phyllodes tumour and stromal sarcoma) with benign stromal tumours (e.g., stromal hyperplasia with atypia, leiomyoma), considering them collectively to be of uncertain malignant potential, but this approach is discouraged. This review presents a contemporary approach to classification and diagnosis of prostatic stromal tumours.</div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">33190920</PMID><DateRevised><Year>2020</Year><Month>11</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1465-3931</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Nov</Month><Day>12</Day></PubDate></JournalIssue><Title>Pathology</Title><ISOAbbreviation>Pathology</ISOAbbreviation></Journal><ArticleTitle>Prostatic stromal proliferations: a review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">S0031-3025(20)30952-1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.pathol.2020.09.017</ELocationID><Abstract><AbstractText>Prostatic stromal proliferations account for the majority of benign tumour-like lesions in the prostate. The most common is nodular hyperplasia, seen in a majority of elderly men. Diagnostic difficulty is encountered with some variants, including stromal hyperplasia with atypia, characterised by degenerative changes of myofibroblasts. In contrast with benign stromal tumours, malignant stromal tumours of the prostate are rare, accounting for less than 0.1% of all prostatic malignancies. The most common are rhabdomyosarcoma (paediatric) and leiomyosarcoma (adults); others include phyllodes tumour and stromal sarcoma. Some authors lump malignant tumours with poor outcome (e.g., phyllodes tumour and stromal sarcoma) with benign stromal tumours (e.g., stromal hyperplasia with atypia, leiomyoma), considering them collectively to be of uncertain malignant potential, but this approach is discouraged. This review presents a contemporary approach to classification and diagnosis of prostatic stromal tumours.</AbstractText><CopyrightInformation>Copyright © 2020 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bostwick</LastName><ForeName>David G</ForeName><Initials>DG</Initials><AffiliationInfo><Affiliation>Bostwick Laboratories, A Division of Poplar Healthcare, Orlando, FL, USA. Electronic address: dbostwick@grangergenetics.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egevad</LastName><ForeName>Lars</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pathology</MedlineTA><NlmUniqueID>0175411</NlmUniqueID><ISSNLinking>0031-3025</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Prostate</Keyword><Keyword MajorTopicYN="N">nodular hyperplasia</Keyword><Keyword MajorTopicYN="N">pathology</Keyword><Keyword MajorTopicYN="N">phyllodes tumour</Keyword><Keyword MajorTopicYN="N">stromal sarcoma</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>09</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>09</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>16</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33190920</ArticleId><ArticleId IdType="pii">S0031-3025(20)30952-1</ArticleId><ArticleId IdType="doi">10.1016/j.pathol.2020.09.017</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Suède</li><li>États-Unis</li></country><region><li>Floride</li><li>Svealand</li></region><settlement><li>Stockholm</li></settlement></list><tree><country name="États-Unis"><region name="Floride"><name sortKey="Bostwick, David G" sort="Bostwick, David G" uniqKey="Bostwick D" first="David G" last="Bostwick">David G. Bostwick</name></region></country><country name="Suède"><region name="Svealand"><name sortKey="Egevad, Lars" sort="Egevad, Lars" uniqKey="Egevad L" first="Lars" last="Egevad">Lars Egevad</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/PoplarV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000170 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000170 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= PoplarV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:33190920
|texte= Prostatic stromal proliferations: a review.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33190920" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PoplarV1
| This area was generated with Dilib version V0.6.37. |  |